Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 491

1.

Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.

Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M.

J Endocr Soc. 2020 Feb 13;4(4):bvaa011. doi: 10.1210/jendso/bvaa011. eCollection 2020 Apr 1.

2.

Baseline plasma aldosterone level and renin activity allowing omission of confirmatory testing in primary aldosteronism.

Kawashima J, Araki E, Naruse M, Kurihara I, Takahashi K, Tamura K, Kobayashi H, Okamura S, Miyauchi S, Yamamoto K, Izawa S, Suzuki T, Tanabe A; JPAS/JRAS Study Group.

J Clin Endocrinol Metab. 2020 Mar 10. pii: dgaa117. doi: 10.1210/clinem/dgaa117. [Epub ahead of print]

PMID:
32157288
3.

Generation of Schubert polynomial series via nanometre-scale photoisomerization in photochromic single crystal and double-probe optical near-field measurements.

Uchiyama K, Suzui H, Nakagomi R, Saigo H, Uchida K, Naruse M, Hori H.

Sci Rep. 2020 Feb 17;10(1):2710. doi: 10.1038/s41598-020-59603-1.

4.

An organoid-based carcinogenesis model induced by in vitro chemical treatment.

Naruse M, Masui R, Ochiai M, Maru Y, Hippo Y, Imai T.

Carcinogenesis. 2020 Feb 12. pii: bgaa011. doi: 10.1093/carcin/bgaa011. [Epub ahead of print]

PMID:
32047892
5.

Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome.

Kobayashi H, Nakamura Y, Abe M, Kurihara I, Itoh H, Ichijo T, Takeda Y, Yoneda T, Katabami T, Tsuiki M, Wada N, Ogawa Y, Sakamoto R, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Yamada T, Okamoto R, Matsuda Y, Fujita M, Watanabe M, Tamura K, Tanabe A, Naruse M; JPAS/JRAS Study Group.

Eur J Endocrinol. 2020 Mar;182(3):265-273. doi: 10.1530/EJE-19-0860.

PMID:
32038030
6.

Dynamic channel selection in wireless communications via a multi-armed bandit algorithm using laser chaos time series.

Takeuchi S, Hasegawa M, Kanno K, Uchida A, Chauvet N, Naruse M.

Sci Rep. 2020 Jan 31;10(1):1574. doi: 10.1038/s41598-020-58541-2.

7.

Miction-induced Hypertension Disclosed by Home Blood Pressure Measurement in a Patient with Small Paraganglioma.

Teragaki M, Yamamoto T, Hosomi K, Tada Y, Maeda K, Nishiya D, Miyazaki C, Takagi Y, Sakanoue Y, Nishida Y, Okuno H, Tsuiki M, Naruse M.

Intern Med. 2020 Mar 15;59(6):793-797. doi: 10.2169/internalmedicine.3255-19. Epub 2019 Dec 6.

8.

Decision making for the multi-armed bandit problem using lag synchronization of chaos in mutually coupled semiconductor lasers.

Mihana T, Mitsui Y, Takabayashi M, Kanno K, Sunada S, Naruse M, Uchida A.

Opt Express. 2019 Sep 16;27(19):26989-27008. doi: 10.1364/OE.27.026989.

PMID:
31674568
9.

Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.

Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Sone M, Tsuiki M, Shibata H, Kawashima J, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Suzuki T; JPAS Study Group.

J Endocr Soc. 2019 Aug 22;3(11):2012-2022. doi: 10.1210/js.2019-00295. eCollection 2019 Nov 1.

10.

Victimization In Childhood Affects Depression In Adulthood Via Neuroticism:A Path Analysis Study.

Tachi S, Asamizu M, Uchida Y, Katayama S, Naruse M, Masuya J, Ichiki M, Inoue T.

Neuropsychiatr Dis Treat. 2019 Oct 3;15:2835-2841. doi: 10.2147/NDT.S220349. eCollection 2019.

11.

Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study.

Naruse M, Mukoyama M, Morinaga J, Miyazaki M, Iseki K, Yamagata K.

Clin Exp Nephrol. 2020 Jan;24(1):45-52. doi: 10.1007/s10157-019-01789-4. Epub 2019 Sep 20.

PMID:
31541337
12.

Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.

Takekoshi K, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Asada S, Kawata N, Naruse M.

Endocr J. 2019 Dec 25;66(12):1063-1072. doi: 10.1507/endocrj.EJ19-0125. Epub 2019 Sep 10.

13.

Generative adversarial network based on chaotic time series.

Naruse M, Matsubara T, Chauvet N, Kanno K, Yang T, Uchida A.

Sci Rep. 2019 Sep 10;9(1):12963. doi: 10.1038/s41598-019-49397-2.

14.

Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.

Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J Jr, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Christian Rump L, Vonend O, Willenberg HS, Fuller PJ, Yang J, Chee NYN, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Dun Wu K, Wu VC, Kratka Z, Barbiero G, Battistel M, Chang CC, Vanderriele PE, Pessina AC.

Hypertension. 2019 Oct;74(4):800-808. doi: 10.1161/HYPERTENSIONAHA.119.13463. Epub 2019 Sep 3.

PMID:
31476901
15.

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M; JPAS Study Group.

J Hum Hypertens. 2020 Jan;34(1):34-42. doi: 10.1038/s41371-019-0229-4. Epub 2019 Aug 28.

PMID:
31462725
16.

Entangled-photon decision maker.

Chauvet N, Jegouso D, Boulanger B, Saigo H, Okamura K, Hori H, Drezet A, Huant S, Bachelier G, Naruse M.

Sci Rep. 2019 Aug 22;9(1):12229. doi: 10.1038/s41598-019-48647-7.

17.

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M; JPAS/JRAS Study Group.

Hypertension. 2019 Sep;74(3):630-638. doi: 10.1161/HYPERTENSIONAHA.119.13131. Epub 2019 Jul 22.

PMID:
31327258
18.

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M.

Eur J Endocrinol. 2019 Sep;181(3):339-350. doi: 10.1530/EJE-19-0047.

PMID:
31319380
19.

Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism.

Wada N, Shibayama Y, Yoneda T, Katabami T, Kurihara I, Tsuiki M, Ichijo T, Ogawa Y, Kawashima J, Sone M, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Tamura K, Kamemura K, Otsuki M, Okamura S, Naruse M; JPAS/JRAS Study Group.

J Endocr Soc. 2019 May 16;3(7):1393-1402. doi: 10.1210/js.2019-00131. eCollection 2019 Jul 1.

20.

On-chip photonic decision maker using spontaneous mode switching in a ring laser.

Homma R, Kochi S, Niiyama T, Mihana T, Mitsui Y, Kanno K, Uchida A, Naruse M, Sunada S.

Sci Rep. 2019 Jul 1;9(1):9429. doi: 10.1038/s41598-019-45754-3.

21.

Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism.

Akasaka H, Yamamoto K, Rakugi H, Nagasawa M, Nakamaru R, Ichijo T, Takeda Y, Kurihara I, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Kamemura K, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Watanabe M, Tamura K, Okamura S, Miyauchi S, Izawa S, Chiba Y, Tanabe A, Naruse M; Japan Primary Aldosteronism Study Group *.

Hypertension. 2019 Aug;74(2):368-374. doi: 10.1161/HYPERTENSIONAHA.119.13006. Epub 2019 Jun 24.

PMID:
31230553
22.

Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.

Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS/JRAS Study Group.

J Hypertens. 2019 Jul;37(7):1513-1520. doi: 10.1097/HJH.0000000000002070.

PMID:
31145370
23.

miRNA299 involvement in CYP11B2 expression in aldosterone-producing adenoma.

Nakano Y, Yoshimoto T, Watanabe R, Murakami M, Fukuda T, Saito K, Fujii Y, Akashi T, Tanaka T, Yamada T, Naruse M, Ogawa Y.

Eur J Endocrinol. 2019 Jul 1;181(1):69-78. doi: 10.1530/EJE-18-0882.

PMID:
31096184
24.

Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.

Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M; JPAS/JRAS Study Group.

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4382-4389. doi: 10.1210/jc.2018-02790.

PMID:
31058960
25.

Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.

Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, Naruse M; JPAS Study Group.

J Hypertens. 2019 Jul;37(7):1493-1499. doi: 10.1097/HJH.0000000000002047.

PMID:
31033727
26.

High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan.

Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M; Japan Primary Aldosteronism Study Group.

Diabetes Care. 2019 May;42(5):938-945. doi: 10.2337/dc18-1293.

PMID:
31010944
27.

Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.

Naruse M, Koike Y, Kamei N, Sakamoto R, Yambe Y, Arimitsu M.

PLoS One. 2019 Apr 3;14(4):e0214727. doi: 10.1371/journal.pone.0214727. eCollection 2019.

28.

Microglial SIRPα regulates the emergence of CD11c+ microglia and demyelination damage in white matter.

Sato-Hashimoto M, Nozu T, Toriba R, Horikoshi A, Akaike M, Kawamoto K, Hirose A, Hayashi Y, Nagai H, Shimizu W, Saiki A, Ishikawa T, Elhanbly R, Kotani T, Murata Y, Saito Y, Naruse M, Shibasaki K, Oldenborg PA, Jung S, Matozaki T, Fukazawa Y, Ohnishi H.

Elife. 2019 Mar 26;8. pii: e42025. doi: 10.7554/eLife.42025.

29.

Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism.

Takeda Y, Umakoshi H, Takeda Y, Yoneda T, Kurihara I, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group.

J Hypertens. 2019 May;37(5):1077-1082. doi: 10.1097/HJH.0000000000001964.

PMID:
30601318
30.

Author Correction: Nanometre-scale pattern formation on the surface of a photochromic crystal by optical near-field induced photoisomerization.

Nakagomi R, Uchiyama K, Suzui H, Hatano E, Uchida K, Naruse M, Hori H.

Sci Rep. 2018 Nov 27;8(1):17474. doi: 10.1038/s41598-018-35959-3.

31.

The dynamics of revascularization after white matter infarction monitored in Flt1-tdsRed and Flk1-GFP mice.

Shimauchi-Ohtaki H, Kurachi M, Naruse M, Shibasaki K, Sugio S, Matsumoto K, Ema M, Yoshimoto Y, Ishizaki Y.

Neurosci Lett. 2019 Jan 23;692:70-76. doi: 10.1016/j.neulet.2018.10.057. Epub 2018 Oct 31.

32.

Why is the environment important for decision making? Local reservoir model for choice-based learning.

Naruse M, Yamamoto E, Nakao T, Akimoto T, Saigo H, Okamura K, Ojima I, Northoff G, Hori H.

PLoS One. 2018 Oct 4;13(10):e0205161. doi: 10.1371/journal.pone.0205161. eCollection 2018.

33.

Nanometre-scale pattern formation on the surface of a photochromic crystal by optical near-field induced photoisomerization.

Nakagomi R, Uchiyama K, Suzui H, Hatano E, Uchida K, Naruse M, Hori H.

Sci Rep. 2018 Sep 27;8(1):14468. doi: 10.1038/s41598-018-32862-9. Erratum in: Sci Rep. 2018 Nov 27;8(1):17474.

34.

Cytokinin-induced expression of OSH1 in a shoot-regenerating rice callus.

Naruse M, Takahashi H, Kurata N, Ito Y.

Plant Biotechnol (Tokyo). 2018 Sep 25;35(3):267-272. doi: 10.5511/plantbiotechnology.18.0614a.

35.

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866.

PMID:
30165444
36.

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine.

Kimura N, Takekoshi K, Naruse M.

J Clin Med. 2018 Aug 27;7(9). pii: E242. doi: 10.3390/jcm7090242. Review.

37.

Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly.

Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T; JPAS Study Group.

J Clin Endocrinol Metab. 2018 Oct 1;103(10):3620-3629. doi: 10.1210/jc.2018-00059.

PMID:
30099522
38.

Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.

Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M.

J Endocr Soc. 2018 May 24;2(8):893-902. doi: 10.1210/js.2018-00055. eCollection 2018 Aug 1.

39.

Scalable photonic reinforcement learning by time-division multiplexing of laser chaos.

Naruse M, Mihana T, Hori H, Saigo H, Okamura K, Hasegawa M, Uchida A.

Sci Rep. 2018 Jul 18;8(1):10890. doi: 10.1038/s41598-018-29117-y.

40.

Development and validation of subtype prediction scores for the workup of primary aldosteronism.

Kobayashi H, Abe M, Soma M, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Shibata H, Kamemura K, Yanase T, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Nanba K, Tanabe A, Suzuki T, Naruse M; JPAS Study Group.

J Hypertens. 2018 Nov;36(11):2269-2276. doi: 10.1097/HJH.0000000000001855.

PMID:
30020243
41.

Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.

Meyer LS, Wang X, Sušnik E, Burrello J, Burrello A, Castellano I, Eisenhofer G, Fallo F, Kline GA, Knösel T, Kocjan T, Lenders JWM, Mulatero P, Naruse M, Nishikawa T, Peitzsch M, Rump LC, Beuschlein F, Hahner S, Gomez-Sanchez CE, Reincke M, Williams TA.

Hypertension. 2018 Sep;72(3):650-657. doi: 10.1161/HYPERTENSIONAHA.118.11465.

42.

The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism.

Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T.

J Endocr Soc. 2018 Mar 22;2(5):398-407. doi: 10.1210/js.2017-00481. eCollection 2018 May 1.

43.

Author Correction: Ultrafast photonic reinforcement learning based on laser chaos.

Naruse M, Terashima Y, Uchida A, Kim SJ.

Sci Rep. 2018 Apr 5;8(1):5769. doi: 10.1038/s41598-018-23476-2.

44.

Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.

Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Suzuki T, Tsuiki M, Naruse M.

Clin Endocrinol (Oxf). 2018 May;88(5):645-651. doi: 10.1111/cen.13582. Epub 2018 Mar 13.

PMID:
29464741
45.

Microglial Activation Induces Generation of Oligodendrocyte Progenitor Cells from the Subventricular Zone after Focal Demyelination in the Corpus Callosum.

Naruse M, Shibasaki K, Shimauchi-Ohtaki H, Ishizaki Y.

Dev Neurosci. 2018;40(1):54-63. doi: 10.1159/000486332. Epub 2018 Jan 25.

PMID:
29393205
46.

Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group.

Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.

PMID:
29358460
47.

Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.

Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K.

Endocr J. 2018 Mar 28;65(3):359-371. doi: 10.1507/endocrj.EJ17-0276. Epub 2018 Jan 20.

48.

BMP4 signaling in NPCs upregulates Bcl-xL to promote their survival in the presence of FGF-2.

Yamamoto H, Kurachi M, Naruse M, Shibasaki K, Ishizaki Y.

Biochem Biophys Res Commun. 2018 Feb 5;496(2):588-593. doi: 10.1016/j.bbrc.2018.01.090. Epub 2018 Jan 19.

PMID:
29353044
49.

Paraganglioma as a risk factor for bone metastasis.

Yokomoto-Umakoshi M, Umakoshi H, Tsuiki M, Ogasawara T, Hamanaka-Hiroshima K, Tanabe A, Tagami T, Shimatsu A, Naruse M.

Endocr J. 2018 Mar 28;65(3):253-260. doi: 10.1507/endocrj.EJ17-0368. Epub 2017 Nov 29.

50.

Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.

Fujii Y, Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T, Nanba K, Tsuiki M, Naruse M; WAVES-J Study Group.

J Hum Hypertens. 2017 Dec;32(1):12-19. doi: 10.1038/s41371-017-0015-0. Epub 2017 Nov 24.

PMID:
29176594

Supplemental Content

Loading ...
Support Center